
  
    
      
        Background_NNP
        The_DT T_NN lymphocyte_NN actin_NN cytoskeleton_NN is_VBZ clearly_RB important_JJ
        in_IN the_DT regulation_NN of_IN cell_NN activity_NN at_IN a_DT variety_NN of_IN
        different_JJ levels_NNS ._. An_DT intact_JJ actin_NN cytoskeleton_NN is_VBZ required_VBN
        for_IN sustained_VBN signals_NNS leading_VBG to_TO T_NN cell_NN activation_NN [_NN 1_CD ]_NN ._.
        T_NN helper_NN and_CC cytolytic_JJ effector_NN cells_NNS reorient_NN their_PRP$
        intracellular_NN components_NNS for_IN vectorial_NN secretion_NN of_IN
        cytokines_NNS [_NN 2_CD ]_NN or_CC cytolytic_JJ components_NNS [_NN 3_CD ]_NN via_IN
        cytoskeletal_NN dependent_JJ mechanisms_NNS ._. Recent_JJ reports_NNS suggest_VBP
        an_DT active_JJ role_NN played_VBN by_IN the_DT T_NN cell_NN cytoskeleton_NN in_IN
        maintaining_VBG spatially_RB defined_VBN molecular_JJ clusters_NNS found_VBD
        within_IN the_DT immunological_JJ synapse_NN -_: a_DT highly_RB structured_VBN
        molecular_JJ array_NN defined_VBN by_IN contact_NN regions_NNS between_IN T_NN cells_NNS
        and_CC antigen_NN presenting_VBG cells_NNS [_NN 4_CD 5_CD 6_CD 7_CD ]_NN ,_, and_CC reviewed_VBD in_IN
        [_NN 8_CD 9_CD ]_NN or_CC NK_NNP cells_NNS and_CC target_NN cells_NNS [_NN 10_CD ]_NN ._. Although_IN the_DT
        actin_NN cytoskeleton_NN has_VBZ been_VBN implicated_VBN in_IN all_PDT these_DT
        processes_VBZ ,_, perhaps_RB its_PRP$ greatest_JJS role_NN is_VBZ in_IN regulating_VBG T_NN
        lymphocyte_NN motility_NN and_CC morphology_NN ._.
        The_DT first_JJ physical_JJ step_NN in_IN directional_NN motility_NN is_VBZ the_DT
        extension_NN of_IN cellular_JJ processes_VBZ termed_VBN pseudopods_NNS [_NN 11_CD ]_NN ._.
        Pseudopodia_NNP are_VBP flattened_VBN ,_, fan_NN shape_NN cellular_JJ protrusions_NNS
        enriched_JJ in_IN signaling_VBG molecules_NNS and_CC cytoskeletal_NN elements_NNS
        including_VBG filamentous_JJ actin_NN ,_, which_WDT is_VBZ preferentially_RB
        nucleated_JJ at_IN the_DT leading_VBG edge_NN of_IN a_DT migrating_VBG cell_NN [_NN 12_CD ]_NN ._.
        A_DT key_JJ candidate_NN for_IN regulation_NN of_IN the_DT T_NN lymphocyte_NN actin_NN
        cytoskeleton_NN is_VBZ the_DT GTP-binding_NNP protein_NN Rho_NNP ._. This_DT small_JJ
        member_NN of_IN the_DT Ras_NNP GTPase_NNP superfamily_RB has_VBZ been_VBN implicated_VBN in_IN
        fibroblast_NN models_NNS of_IN integrin_NN dependent_JJ actin_NN stress_NN fiber_NN
        formation_NN ,_, focal_JJ contact_NN assembly_NN [_NN 13_CD ]_NN ,_, and_CC gene_NN
        induction_NN via_IN the_DT serum_NN response_NN element_NN [_NN 14_CD ]_NN ._. Studies_NNPS
        of_IN Rho_NNP function_NN have_VBP been_VBN facilitated_JJ by_IN the_DT use_NN of_IN
        specific_JJ toxins_NNS such_JJ as_IN 
        Clostridium_NNP botulinum_NN toxin_NN C_NNP 3_CD which_WDT
        catalyses_NNS the_DT ADP-ribosylation_NNP and_CC inactivation_NN of_IN Rho_NNP [_NN 15_CD
        16_CD 17_CD ]_NN ._. The_DT function_NN of_IN this_DT GTPase_NNP and_CC related_VBN family_NN
        members_NNS such_JJ as_IN Rac_NNP and_CC Cdc_NNP 42_CD has_VBZ been_VBN extensively_RB studied_VBN
        in_IN the_DT fibroblast_NN model_NN ._. In_IN this_DT system_NN it_PRP has_VBZ been_VBN shown_VBN
        that_IN Rho_NNP function_NN is_VBZ necessary_JJ for_IN the_DT production_NN of_IN actin_NN
        stress_NN fibers_NNS [_NN 13_CD ]_NN ._. However_RB ,_, in_IN cells_NNS that_WDT are_VBP
        considered_VBN highly_RB motile_NN and_CC circulate_VB through_IN various_JJ
        compartments_NNS of_IN the_DT body_NN (_( such_JJ as_IN T_NN lymphocytes_NNS )_) ,_, actin_NN
        stress_NN fibers_NNS have_VBP yet_RB to_TO be_VB identified_VBN ._. By_IN comparison_NN to_TO
        adherent_NN cells_NNS such_JJ as_IN fibroblasts_NNS ,_, less_JJR work_NN has_VBZ been_VBN done_VBN
        within_IN the_DT formed_VBN elements_NNS of_IN the_DT blood_NN ,_, in_IN particular_JJ ,_,
        studies_NNS addressing_VBG the_DT role_NN played_VBN by_IN Rho_NNP in_IN the_DT
        maintenance_NN of_IN T_NN lymphocyte_NN cytoarchitecture_NN ._.
        The_DT involvement_NN of_IN Rho_NNP GTPases_NNP in_IN regulating_VBG integrin_NN
        dependent_JJ events_NNS such_JJ as_IN leukocyte_NN homotypic_JJ aggregation_NN
        and_CC in_IN chemokine_NN upregulation_NN of_IN integrin-mediated_JJ adhesion_NN
        has_VBZ recently_RB been_VBN identified_VBN [_NN 18_CD 19_CD ]_NN ._. ADP-ribosylation_NNP
        of_IN Rho_NNP in_IN neutrophils_NNS by_IN treatment_NN with_IN C_NNP 3_CD not_RB only_RB
        inhibits_NNS cellular_JJ locomotion_NN ,_, but_CC augments_NNS chemoattractant_NN
        induced_VBD actin_NN polymerization_NN [_NN 20_CD 21_CD ]_NN ._. Moreover_RB ,_,
        inactivation_NN of_IN Rho_NNP in_IN monocytic_JJ cells_NNS leads_VBZ to_TO accelerated_VBN
        formation_NN of_IN filopodia_NN ,_, and_CC it_PRP has_VBZ been_VBN proposed_VBN that_IN Rho_NNP
        is_VBZ a_DT negative_JJ regulator_NN of_IN actin_NN polymerization_NN within_IN this_DT
        cell_NN type_NN [_NN 22_CD ]_NN ._. Active_JJ Rho_NNP is_VBZ also_RB required_VBN for_IN normal_JJ
        morphology_NN ,_, motility_NN ,_, and_CC cytolytic_JJ activity_NN of_IN IL-_NNP 2_CD
        activated_VBN NK_NNP cells_NNS [_NN 23_CD 24_CD ]_NN ._. We_PRP and_CC others_NNS have_VBP
        demonstrated_VBN the_DT importance_NN of_IN Rho_NNP in_IN T_NN lymphocyte_NN
        activation_NN [_NN 25_CD 26_CD ]_NN ._. Given_VBN the_DT role_NN played_VBN by_IN Rho_NNP in_IN the_DT
        regulation_NN of_IN actin_NN microfilaments_NNS in_IN other_JJ cell_NN types_NNS ,_, and_CC
        the_DT indispensability_NN of_IN a_DT functional_JJ actin_NN cytoskeleton_NN in_IN
        lymphocyte_NN motility_NN and_CC activation_NN ,_, it_PRP is_VBZ of_IN importance_NN to_TO
        study_VB Rho_NNP 's_POS role_NN in_IN the_DT regulation_NN of_IN T_NN lymphocyte_NN integrin_NN
        function_NN and_CC maintenance_NN of_IN cytoskeletal_NN organization_NN ._.
      
      
        Results_NNS
        
          Electroporation_NNP of_IN C_NNP 3_CD induces_VBZ complete_JJ
          ADP-ribosylation_NNP of_IN Rho_NNP in_IN HPB-ALL_NNP
          Western_NNP blotting_VBG analysis_NN confirmed_VBD the_DT presence_NN of_IN
          RhoA_NNP (_( ~_NN 25_CD kDa_NN )_) in_IN the_DT human_JJ T_NN cell_NN lines_NNS HPB-ALL_NNP and_CC CEM_NNP
          (_( Figure_NN 1_CD A_DT )_) ._. The_DT bacterial_JJ toxin_NN C_NNP 3_CD from_IN 
          Clostridium_NNP botulinum_NN ribosylates_NNS
          asparagine_NN 41_CD of_IN the_DT small_JJ GTPase_NNP Rho_NNP [_NN 15_CD 16_CD ]_NN ,_,
          resulting_VBG in_IN its_PRP$ inactivation_NN ._. C_NNP 3_CD (_( 25_CD μg_NN /_NN ml_NN )_) was_VBD
          electroporated_JJ into_IN the_DT T_NN cell_NN line_NN HPB-ALL_NNP as_IN described_VBN
          in_IN the_DT Materials_NNPS and_CC Methods_NNP ._. After_IN thorough_JJ washing_NN ,_, the_DT
          cells_NNS were_VBD incubated_JJ for_IN 1_CD hour_NN at_IN 37_CD °_NN C_NNP to_TO allow_VB 
          in_IN vivo_NN ribosylation_NN ,_, then_RB
          sonicated_JJ and_CC lysates_NNS subjected_VBN to_TO further_VB C_NNP 3_CD
          ribosylation_NN by_IN the_DT addition_NN of_IN 2_CD μCi_NN [_NN 32_CD P_NN ]_NN -_: NAD_NNP and_CC 1_CD μg_NN
          of_IN C_NNP 3_CD in_IN ribosylation_NN buffer_NN ._. By_IN this_DT method_NN ,_, any_DT further_JJ
          ADP_NNP ribosylation_NN of_IN Rho_NNP can_MD be_VB identified_VBN 
          in_IN vitro_NN after_IN 
          in_IN vivo_NN ribosylation_NN ,_, thus_RB serving_VBG
          as_IN a_DT measure_NN of_IN the_DT efficiency_NN of_IN the_DT electroporation_NN
          procedure_NN for_IN introducing_VBG C_NNP 3_CD exoenzyme_NN into_IN HPB-ALL_NNP cells_NNS
          [_NN 31_CD ]_NN ._. As_IN figure_NN 1_CD Bdemonstrates_NNP ,_, electroporation_NN of_IN C_NNP 3_CD
          transferase_NN (_( Figure_NN 1_CD B_NNP ,_, lane_NN 3_LS )_) prior_RB to_TO cell_NN disruption_NN
          prevented_VBD further_JJ ribosylation_NN of_IN Rho_NNP proteins_NNS in_IN the_DT
          cell_NN lysates_NNS ._. The_DT technique_NN of_IN electroporation_NN of_IN C_NNP 3_CD was_VBD
          very_RB efficient_JJ ,_, as_RB even_RB longer_JJR autoradiographic_JJ exposures_NNS
          of_IN the_DT gel_NN did_VBD not_RB demonstrate_VB incorporation_NN of_IN [_NN
          32_CD P_NN ]_NN -_: NAD_NNP (_( data_NNS not_RB shown_VBN )_) ._. Thus_RB electroporation_NN of_IN the_DT
          exoenzyme_NN C_NNP 3_CD fully_RB ribosylates_NNS Rho_NNP 
          in_IN vivo_NN ,_, to_TO the_DT extent_NN that_IN no_DT
          further_RB 
          in_IN vitro_NN ribosylation_NN of_IN Rho_NNP can_MD be_VB
          detected_VBN after_IN cell_NN lysis_NNS ._.
        
        
          Alteration_NNP of_IN HPB-ALL_NNP morphology_NN by_IN C_NNP 3_CD
          exoenzyme_NN
          Inactivation_NNP of_IN Rho_NNP did_VBD not_RB affect_VB the_DT constitutively_RB
          high_JJ adhesion_NN of_IN HPB-ALL_NNP cells_NNS to_TO the_DT extracellular_NN
          matrix_NN protein_NN fibronectin_NN (_( Fn_NNP )_) (_( Figure_NN 2_LS )_) ._. When_WRB HPB-ALL_NNP
          cells_NNS are_VBP plated_JJ onto_IN β_NN 1_CD integrin_NN substrate_NN such_JJ as_IN
          fibronectin_NN ,_, vascular_NN cell_NN adhesion_NN molecule-_NN 1_CD (_( VCAM-_NNP 1_LS )_) ,_,
          or_CC even_RB antibodies_NNS to_TO α_NN 4_CD β_NN 1_CD integrins_NNS ,_, they_PRP respond_VBP by_IN
          extending_VBG pseudopodia_NN and_CC displaying_VBG a_DT highly_RB flattened_VBN ,_,
          spread_NN morphology_NN (_( figure_NN 3_CD ,_, panels_NNS 4_CD ,_, 7_CD ,_, and_CC 10_CD ,_, and_CC ref_NN
          [_NN 32_CD ]_NN )_) ._. However_RB ,_, electroporation_NN of_IN C_NNP 3_CD appeared_VBD to_TO
          alter_VB HPB-ALL_NNP morphology_NN resulting_VBG in_IN the_DT extension_NN of_IN
          very_RB fine_NN branched_VBN finger-like_JJ cellular_JJ processes_VBZ when_WRB
          cells_NNS were_VBD plated_JJ on_IN the_DT β_NN 1_CD integrin_NN substrates_NNS Fn_NNP
          (_( figure_NN 3_CD ,_, panel_NN 6_CD )_) ,_, VCAM-_NNP 1_CD (_( figure_NN 3_CD ,_, panel_NN 9_CD )_) ,_, or_CC a_DT mAb_NN
          specific_JJ for_IN β_NN 1_CD integrins_NNS (_( figure_NN 3_CD ,_, panel_NN 12_CD )_) ._. This_DT also_RB
          occurred_VBN for_IN another_DT T_NN cell_NN line_NN ,_, HSB-_NNP 1_CD (_( data_NNS not_RB shown_VBN )_) ,_,
          and_CC in_IN activated_VBN primary_JJ T_NN lymphocytes_NNS (_( Table_NNP 1_LS )_) ._.
          Untreated_NNP HPB-ALL_NNP ,_, mock_JJ electroporated_JJ control_NN HPB-ALL_NNP ,_,
          or_CC C_NNP 3_CD treated_VBN HPB-ALL_NNP do_VBP not_RB extend_VB pseudopodia_NN on_IN the_DT
          non-specific_JJ cell_NN attachment_NN substrate_NN poly-_NN L-_NNP lysine_NN
          (_( figure_NN 3_CD ,_, panels_NNS 13_CD -_: 15_CD )_) ,_, demonstrating_VBG the_DT requirement_NN
          for_IN integrin_NN dependent_JJ signals_NNS in_IN both_DT the_DT normal_JJ
          spreading_VBG morphology_NN of_IN HBP-ALL_NNP ,_, and_CC the_DT C_NNP 3_CD induced_VBN
          morphological_JJ changes_NNS in_IN this_DT cell_NN type_NN ._.
        
        
          RhoA_NNP immunolocalization_NN in_IN normal_JJ and_CC C_NNP 3_CD treated_VBN
          HPB-ALL_NNP cells_NNS spreading_VBG on_IN fibronectin_NN
          Immunolocalization_NNP of_IN the_DT GTPase_NNP RhoA_NNP was_VBD performed_VBN to_TO
          determine_VB if_IN inactivation_NN by_IN C_NNP 3_CD exoenzyme_NN caused_VBD spatial_NN
          redistribution_NN of_IN RhoA_NNP in_IN HPB-ALL_NNP ._. As_IN figure_NN
          4_CD demonstrates_VBZ ,_, untreated_JJ HPB-ALL_NNP cells_NNS display_VBP a_DT diffuse_NN
          staining_VBG pattern_NN of_IN RhoA_NNP ,_, with_IN small_JJ punctate_NN
          microclusters_NNS throughout_IN the_DT normal_JJ pseudopodial_NN
          extensions_NNS (_( figure_NN 4_CD ,_, left_VBD panels_NNS ,_, arrows_NNS )_) ._. Staining_NNP with_IN
          secondary_JJ antibody_NN alone_RB was_VBD negative_JJ (_( data_NNS not_RB shown_VBN )_) ._.
          Inactivation_NNP of_IN Rho_NNP by_IN electroporation_NN of_IN C_NNP 3_CD exoenzyme_NN
          did_VBD not_RB seem_VB to_TO cause_VB a_DT large_JJ overall_JJ redistribution_NN of_IN
          RhoA_NNP in_IN spread_NN HPB-ALL_NNP ._. However_RB ,_, RhoA_NNP appeared_VBD to_TO be_VB in_IN
          relatively_RB larger_JJR clusters_NNS distributed_VBN along_IN the_DT aberrant_NN
          pseudopodial_NN structures_NNS with_IN no_DT diffuse_NN staining_VBG observed_VBN
          (_( figure_NN 4_CD ,_, right_JJ panels_NNS ,_, arrows_NNS )_) ._.
        
        
          Altered_NNP pseudopodia_NN are_VBP rich_JJ in_IN filamentous_JJ
          actin_NN
          The_DT Rho_NNP family_NN of_IN GTPases_NNP is_VBZ largely_RB responsible_JJ for_IN
          maintenance_NN of_IN cell_NN shape_NN in_IN a_DT variety_NN of_IN cell_NN types_NNS ,_, and_CC
          this_DT involves_VBZ regulation_NN of_IN the_DT actin_NN cytoskeleton_NN ._. To_TO
          localize_NN filamentous_JJ actin_NN within_IN HPB-ALL_NNP ,_, cells_NNS adherent_NN
          to_TO VCAM-_NNP 1_CD were_VBD fixed_VBN and_CC stained_JJ with_IN TRITC-phalloidin_NNP ._.
          Control_NNP electroporated_JJ cells_NNS display_VBP rather_RB diffuse_NN
          filamentous_JJ actin_NN staining_VBG in_IN elongated_JJ pseudopodial_NN
          processes_VBZ that_WDT flatten_VB and_CC spread_VB out_IN on_IN their_PRP$ termini_NN ,_,
          and_CC there_EX are_VBP multiple_JJ filopodia_NN extending_VBG from_IN these_DT
          processes_VBZ and_CC from_IN the_DT cell_NN body_NN (_( figure_NN 5_CD A_DT ,_, arrows_NNS )_) ._.
          Cells_NNP that_WDT had_VBD been_VBN treated_VBN with_IN C_NNP 3_CD exoenzyme_NN however_RB all_DT
          contain_VBP highly_RB enriched_JJ filamentous_JJ actin_NN within_IN the_DT
          extended_VBN pseudopods_NNS ._. This_DT is_VBZ true_JJ on_IN the_DT substrates_NNS FN_NNP
          and_CC anti-β_JJ 1_CD integrin_NN mAb_NN (_( data_NNS not_RB shown_VBN )_) ._. In_IN the_DT C_NNP 3_CD
          electroporated_JJ cells_NNS ,_, small_JJ filopodia_NN extending_VBG from_IN the_DT
          cell_NN body_NN are_VBP absent_JJ ,_, and_CC multiple_JJ branched_VBN pseudopodial_NN
          structures_NNS are_VBP largely_RB enriched_JJ in_IN filamentous_JJ actin_NN
          (_( Figure_NN 5_CD B_NNP ,_, arrows_NNS )_) ._. Of_IN interest_NN ,_, electroporation_NN of_IN C_NNP 3_CD
          in_IN conjunction_NN with_IN FITC-labeled_NNP monomers_NNS of_IN actin_NN did_VBD
          not_RB demonstrate_VB incorporation_NN of_IN FITC-actin_NNP in_IN the_DT
          altered_VBN pseudopods_NNS at_IN early_JJ time_NN points_NNS (_( data_NNS not_RB shown_VBN )_) ,_,
          suggesting_VBG that_IN the_DT filamentous_JJ actin_NN in_IN the_DT altered_VBN
          pseudopods_NNS initially_RB results_VBZ from_IN rearrangement_NN of_IN
          pre-formed_JJ actin_NN filaments_NNS ._.
        
        
          Time_NN lapse_NN microscopy_NN of_IN C_NNP 3_CD treated_VBN cells_NNS
          In_IN fibroblast_NN models_NNS ,_, inactivation_NN of_IN Rho_NNP causes_NNS
          retraction_NN of_IN pre-formed_JJ pseudopods_NNS with_IN a_DT resultant_JJ
          deposition_NN of_IN parallel_JJ tracks_NNS of_IN thin_JJ dendritic_JJ processes_VBZ
          [_NN 17_CD ]_NN ,_, a_DT phenotype_NN ultimately_RB resembling_VBG that_WDT seen_VBN in_IN
          C_NNP 3_CD treated_VBN HPB-ALL_NNP ._. The_DT phenotype_NN induced_VBN by_IN C_NNP 3_CD mediated_JJ
          ribosylation_NN of_IN Rho_NNP in_IN HPB-ALL_NNP could_MD result_VB from_IN either_DT
          aberrant_NN retraction_NN of_IN recently_RB formed_VBN pseudopods_NNS ,_, or_CC
          altered_VBD pseudopodial_NN extension_NN ._. These_DT possibilities_NNS were_VBD
          explored_JJ using_VBG video_NN time-lapse_JJ microscopy_NN ._. Figure_NN
          6_CD demonstrates_VBZ HPB-ALL_NNP spreading_VBG on_IN VCAM-_NNP 1_CD over_IN a_DT period_NN
          of_IN 1_CD hour_NN ,_, where_WRB images_NNS from_IN the_DT first_JJ 10_CD minutes_NNS were_VBD
          obtained_VBN from_IN recorded_VBN videotape_NN ,_, followed_VBN by_IN a_DT 60_CD minute_NN
          time_NN point_NN ._. Untreated_NNP cells_NNS and_CC mock_JJ electroporated_JJ cells_NNS
          demonstrate_VBP normal_JJ HPB-ALL_NNP cell_NN spreading_VBG (_( figure_NN 6_CD ,_, see_VBP
          arrows_NNS )_) ._. They_PRP extend_VBP thick_JJ pseudopodia_NN with_IN fanned_VBD
          termini_NN ,_, and_CC their_PRP$ cell_NN bodies_NNS are_VBP flattened_VBN and_CC oval_NN in_IN
          shape_NN ._. The_DT C_NNP 3_CD induced_VBN phenotype_NN forms_NNS at_IN the_DT onset_NN of_IN
          cell_NN spreading_VBG (_( figure_NN 6_CD ,_, see_VBP arrows_NNS )_) ._. The_DT finger-like_JJ
          extensions_NNS initially_RB form_VBP from_IN a_DT rounded_JJ cell_NN body_NN and_CC
          elongate_VB throughout_IN the_DT duration_NN of_IN the_DT assay_NN ._. The_DT
          stellate_NN projections_NNS are_VBP clearly_RB delineated_JJ even_RB at_IN their_PRP$
          termini_NN ,_, and_CC the_DT cell_NN bodies_NNS do_VBP not_RB demonstrate_VB a_DT
          flattened_VBN ,_, oval_NN ,_, or_CC spindle_NN phenotype_NN ._. Thus_RB ,_, the_DT C_NNP 3_CD
          induced_VBN stellate_NN phenotype_NN is_VBZ not_RB primarily_RB due_JJ to_TO
          aberrant_NN pseudopodial_NN retraction_NN ,_, but_CC an_DT altered_VBN
          pseudopodial_NN extension_NN ._. Also_RB of_IN note_NN was_VBD the_DT effect_NN of_IN C_NNP 3_CD
          on_IN the_DT dynamic_JJ maintenance_NN of_IN pseudopodia_NN ._. Under_IN normal_JJ
          or_CC control_NN electroporation_NN conditions_NNS ,_, some_DT of_IN the_DT VCAM-_NNP 1_CD
          adherent_NN cells_NNS would_MD retract_NN pseudopodia_NN ,_, then_RB form_NN new_JJ
          extensions_NNS in_IN different_JJ directions_NNS ._. This_DT activity_NN was_VBD
          clearly_RB inhibited_VBD in_IN the_DT C_NNP 3_CD treated_VBN cells_NNS ._. Once_RB the_DT
          aberrant_NN finger-like_JJ projections_NNS were_VBD formed_VBN ,_, no_DT
          pseudopodial_NN retraction_NN was_VBD noted_VBN during_IN this_DT time_NN
          period_NN ,_, and_CC the_DT cells_NNS became_VBD completely_RB immobile_NN ._.
          Quantification_NNP of_IN the_DT original_JJ movies_NNS indicate_VBP that_IN only_RB
          1_CD ._. 7_CD %_NN (_( 1_CD /_NN 60_CD )_) of_IN the_DT C_NNP 3_CD -_: treated_VBN cells_NNS were_VBD motile_NN whereas_IN
          34_CD ._. 9_CD %_NN (_( 45_CD /_NN 129_CD )_) of_IN mock-electroporated_JJ cells_NNS displayed_VBD
          motility_NN ._. See_VB additional_JJ file_NN 1_CD :_: C_NNP 3_CD ._. movand_NN
          file_NN 2_CD :_: mock_JJ ._. movfor_NN the_DT original_JJ movies_NNS ._.
          Additional_JJ File_NNP 1_CD
          C_NNP 3_CD transfection_NN on_IN VCAM_NNP C_NNP 3_CD exoenzyme_NN transfected_JJ into_IN
          HPB-ALL_NNP cells_NNS inhibits_NNS motility_NN on_IN immobilized_JJ VCAM-_NNP 1_CD
          substrate_NN ._.
          Click_NNP here_RB for_IN file_NN
          Additional_JJ File_NNP 2_CD
          Mock_NNP transfection_NN on_IN VCAM_NNP Mock_NNP transfected_JJ HPB-ALL_NNP
          cells_NNS have_VBP normal_JJ motility_NN on_IN immobilized_JJ VCAM-_NNP 1_CD
          substrate_NN ._.
          Click_NNP here_RB for_IN file_NN
        
      
      
        Discussion_NNP
        In_IN the_DT present_JJ study_NN ,_, we_PRP demonstrate_VBP that_IN
        ADP-ribosylation_NNP of_IN the_DT GTPase_NNP Rho_NNP in_IN HPB-ALL_NNP cells_NNS does_VBZ
        not_RB result_VB in_IN a_DT decrease_NN in_IN constitutively_RB high_JJ adhesion_NN to_TO
        the_DT extracellular_NN matrix_NN component_NN fibronectin_NN ._. However_RB ,_,
        inactivation_NN of_IN Rho_NNP protein_NN does_VBZ result_NN in_IN the_DT aberrant_NN
        extension_NN of_IN finger-like_JJ ,_, branched_VBN dendritic_JJ projections_NNS in_IN
        HBP-ALL_NNP cells_NNS when_WRB plated_JJ on_IN the_DT substrates_NNS VCAM-_NNP 1_CD ,_,
        fibronectin_NN ,_, and_CC mAb_NN specific_JJ for_IN β_NN 1_CD integrins_NNS ._. Altered_NNP
        pseudopodial_NN extension_NN required_VBD β_NN 1_CD integrin_NN signaling_VBG ,_, as_IN
        C_NNP 3_CD treated_VBN cells_NNS plated_JJ on_IN the_DT non-specific_JJ cell_NN attachment_NN
        factor_NN poly-_NN L-_NNP lysine_NN did_VBD not_RB extend_VB dendritic_JJ like_IN
        processes_NNS ._. Electroporation_NNP of_IN polyclonal_NN antibodies_NNS
        specific_JJ for_IN RhoA_NNP mimicked_JJ the_DT C_NNP 3_CD induced_VBN phenotype_NN (_( data_NNS
        not_RB shown_VBN )_) ._. The_DT C_NNP 3_CD induced_VBN extensions_NNS were_VBD rich_JJ in_IN
        filamentous_JJ actin_NN ,_, and_CC C_NNP 3_CD treated_VBN HPB-ALL_NNP cell_NN bodies_NNS
        apparently_RB lacked_VBD filopodial_NN actin_NN microspikes_NNS ,_, present_JJ in_IN
        normal_JJ spreading_VBG cells_NNS ._. Immunolocalization_NNP studies_NNS of_IN RhoA_NNP
        in_IN C_NNP 3_CD treated_VBN HBP-ALL_NNP cells_NNS spreading_VBG on_IN fibronectin_NN showed_VBD
        no_DT gross_JJ differences_NNS in_IN RhoA_NNP distribution_NN ,_, however_RB clusters_NNS
        of_IN RhoA_NNP were_VBD more_RBR delineated_JJ along_IN the_DT finger-like_JJ
        dendritic_JJ processes_NNS of_IN the_DT C_NNP 3_CD treated_VBN cells_NNS ._. Thus_RB ,_,
        functional_JJ Rho_NNP is_VBZ required_VBN for_IN the_DT proper_JJ extension_NN and_CC
        retraction_NN of_IN pseudopods_NNS in_IN T_NN lymphocytes_NNS on_IN β_NN 1_CD integrin_NN
        substrates_NNS ._.
        A_DT large_JJ body_NN of_IN work_NN has_VBZ described_VBN the_DT morphological_JJ
        functions_NNS regulated_VBN by_IN small_JJ GTPases_NNP of_IN the_DT Rho_NNP subfamily_RB ._.
        Members_NNS of_IN this_DT family_NN include_VBP RhoA_NNP ,_, RhoB_NNP ,_, RhoC_NNP (_( which_WDT are_VBP
        isoforms_NNS )_) ,_, Cdc_NNP 42_CD ,_, G_NNP 25_CD K_NNP ,_, RhoG_NNP ,_, Rac_NNP 1_CD ,_, Rac_NNP 2_CD ,_, and_CC TC_NNP 10_CD
        (_( reviewed_VBN in_IN [_NN 34_CD ]_NN )_) ._. In_IN fibroblast_NN models_NNS ,_, these_DT GTPases_NNP
        have_VBP been_VBN proposed_VBN to_TO act_VB in_IN a_DT concerted_JJ hierarchy_NN to_TO
        coordinately_RB regulate_VB distinct_JJ morphological_JJ features_NNS ._.
        Filopodia_NNP formation_NN of_IN short_JJ filamentous_JJ actin_NN microspikes_NNS
        gives_VBZ way_NN to_TO membrane_NN ruffling_VBG and_CC lamellipodia_NN formation_NN ,_,
        culminating_VBG in_IN the_DT organized_VBN production_NN of_IN actin_NN stress_NN
        fibers_NNS ._. This_DT has_VBZ lead_VBN to_TO the_DT hypothesis_NNS that_IN small_JJ GTP_NNP
        binding_JJ proteins_NNS act_VBP sequentially_RB ,_, in_IN the_DT GTPase_NNP cascade_NN
        Cdc_NNP 42_CD →_NN Rac_NNP →_NN Rho_NNP [_NN 35_CD ]_NN ._. Facilitating_NNP the_DT study_NN of_IN Rho_NNP in_IN
        regulation_NN of_IN cell_NN activity_NN has_VBZ been_VBN the_DT use_NN of_IN C_NNP 3_CD
        exoenzyme_NN ,_, a_DT toxin_NN from_IN 
        Clostridium_NNP botulinum_NN that_IN
        ADP-ribosylates_NNP [_NN 15_CD 16_CD ]_NN and_CC inactivates_NNS Rho_NNP proteins_NNS ._.
        Although_IN ribosylation_NN of_IN other_JJ Rho_NNP family_NN proteins_NNS such_JJ as_IN
        Rac_NNP 1_CD can_MD occur_VB with_IN C_NNP 3_CD [_NN 33_CD ]_NN ,_, this_DT seemed_VBD to_TO be_VB very_RB weak_JJ
        [_NN 13_CD ]_NN ._. In_IN our_PRP$ work_NN ,_, C_NNP 3_CD electroporated_JJ into_IN the_DT T_NN cell_NN
        line_NN HPB-ALL_NNP caused_VBD complete_JJ ADP-ribosylation_NNP of_IN Rho_NNP
        proteins_NNS (_( ~_NN 25_CD kDa_NN )_) ._. Although_IN Rac_NNP 1_CD and_CC Cdc_NNP 42_CD were_VBD identified_VBN
        in_IN western_JJ blots_NNS of_IN whole_JJ cell_NN lysates_NNS prepared_VBN from_IN the_DT T_NN
        cell_NN lines_NNS HPB-ALL_NNP ,_, CEM_NNP ,_, HSB_NNP (_( data_NNS not_RB shown_VBN )_) ,_, and_CC PB_NNP human_JJ
        T_NN lymphocytes_NNS (_( data_NNS not_RB shown_VBN )_) ,_, there_EX was_VBD no_DT detection_NN of_IN
        ribosylation_NN in_IN the_DT lower_JJR molecular_JJ weight_NN Rac_NNP and_CC Cdc_NNP 42_CD
        related_VBN GTPases_NNP in_IN HPB-ALL_NNP cells_NNS ,_, indicating_VBG the_DT
        specificity_NN of_IN C_NNP 3_CD ._.
        Previous_JJ reports_NNS have_VBP demonstrated_VBN that_IN ADP-ribosylation_NNP
        of_IN B-_NNP lymphoid_NN cell_NN lines_NNS by_IN C_NNP 3_CD treatment_NN inhibits_NNS phorbol_NN
        ester_NN induced_VBD cellular_JJ homotypic_JJ aggregation_NN [_NN 18_CD ]_NN ._. Also_RB ,_,
        phorbol_NN ester_NN and_CC chemoattractant_NN (_( IL-_NNP 8_CD and_CC fMLP_NN )_) induced_VBN
        pre-_NN B_NNP lymphoblastoid_NN adhesion_NN to_TO VCAM-_NNP 1_CD and_CC neutrophil_NN
        adhesion_NN to_TO fibrinogen_NN was_VBD abrogated_JJ in_IN a_DT dose-dependent_JJ
        manner_NN by_IN C_NNP 3_CD exoenzyme_NN [_NN 36_CD ]_NN ._. This_DT may_MD indicate_VB that_IN in_IN
        cells_NNS of_IN hematopoietic_JJ lineages_NNS ,_, the_DT induction_NN of_IN an_DT
        increased_VBN adhesive_NN state_NN may_MD be_VB susceptible_JJ to_TO regulation_NN
        by_IN Rho_NNP proteins_NNS ._. However_RB ,_, we_PRP have_VBP recently_RB demonstrated_VBN
        that_WDT induced_VBD adhesion_NN of_IN primary_JJ T_NN lymphocytes_NNS to_TO
        fibronectin_NN is_VBZ unaffected_JJ by_IN Rho_NNP inactivation_NN [_NN 25_CD ]_NN ,_, and_CC
        data_NNS presented_VBN here_RB suggests_VBZ that_IN constitutively_RB high_JJ
        adhesion_NN of_IN HPB-ALL_NNP cells_NNS to_TO β_NN 1_CD integrin_NN substrate_NN is_VBZ
        unaffected_JJ by_IN C_NNP 3_CD treatment_NN ._. Others_NNS have_VBP demonstrated_VBN that_DT
        inactivation_NN of_IN Rho_NNP in_IN monocytes_NNS promotes_VBZ cellular_JJ adhesion_NN
        to_TO β_NN 1_CD integrin_NN substrates_NNS [_NN 37_CD ]_NN ._. Static_NNP cell_NN adhesion_NN
        studies_NNS rely_VBP on_IN a_DT number_NN of_IN factors_NNS including_VBG integrin_NN
        affinity_NN regulation_NN ,_, integrin_NN avidity_NN /_NN clustering_VBG ,_, and_CC shear_NN
        resistant_JJ cell_NN shape_NN changes_NNS ._. Factors_NNP affecting_VBG adhesion_NN
        can_MD do_VB so_RB by_IN regulating_VBG any_DT number_NN of_IN these_DT parameters_NNS ._.
        Thus_RB the_DT effects_NNS due_JJ to_TO Rho_NNP inactivation_NN on_IN cell_NN adhesion_NN
        may_MD not_RB only_RB influence_VB one_CD or_CC more_JJR of_IN these_DT parameters_NNS ,_, but_CC
        also_RB be_VB cell_NN type_NN specific_JJ even_RB amongst_IN the_DT cells_NNS of_IN the_DT
        hematopoeitic_JJ lineage_NN ._.
        The_DT phenotype_NN induced_VBN by_IN ADP-ribosylation_NNP of_IN Rho_NNP in_IN T_NN
        lymphocytes_NNS appeared_VBD different_JJ than_IN that_DT induced_VBD in_IN
        fibroblast_NN models_NNS ,_, where_WRB microinjection_NN of_IN C_NNP 3_CD results_NNS in_IN
        fibroblast_NN retraction_NN of_IN pseudopodia_NN ,_, with_IN the_DT cell_NN body_NN
        rounding_VBG up_RP eventually_RB to_TO become_VB non-adherent_JJ [_NN 17_CD ]_NN ._.
        Video_NNP time-lapse_JJ microscopy_NN demonstrated_VBD the_DT elongation_NN of_IN
        aberrant_NN pseudopods_NNS in_IN HPB-ALL_NNP cells_NNS plated_JJ on_IN the_DT β_NN 1_CD
        substrate_NN VCAM-_NNP 1_CD ,_, rather_RB than_IN an_DT altered_VBN retraction_NN of_IN
        already_RB formed_VBN pseudopods_NNS ._. These_DT results_NNS suggest_VBP an_DT altered_VBN
        pseudopodial_NN extension_NN although_IN a_DT defect_NN in_IN contractibility_NN
        could_MD be_VB involved_VBN as_IN a_DT secondary_JJ mechanism_NN for_IN formation_NN of_IN
        aberrant_NN processes_NNS ._. This_DT phenotype_NN also_RB coincided_VBD with_IN the_DT
        complete_JJ loss_NN of_IN cellular_JJ motility_NN in_IN HPB-ALL_NNP ,_, even_RB though_IN
        adhesion_NN to_TO substrate_NN was_VBD not_RB noticeably_RB altered_VBN ._. It_PRP is_VBZ
        also_RB important_JJ to_TO note_VB that_IN normal_JJ and_CC C_NNP 3_CD induced_VBN aberrant_NN
        HPB-ALL_NNP spreading_VBG on_IN Fn_NNP or_CC VCAM-_NNP 1_CD is_VBZ dependent_JJ on_IN signals_NNS
        generated_VBN through_IN β_NN 1_CD integrins_NNS ,_, as_IN both_DT morphologies_NNS could_MD
        be_VB seen_VBN when_WRB untreated_JJ or_CC C_NNP 3_CD treated_VBN HPB-ALL_NNP were_VBD plated_JJ on_IN
        the_DT β_NN 1_CD specific_JJ mAb_NN 33_CD B_NNP 6_CD ._. When_WRB these_DT same_JJ cells_NNS are_VBP plated_JJ
        on_IN the_DT non-specific_JJ cell_NN attachment_NN factor_NN poly-_NN L-_NNP lysine_NN ,_,
        cells_NNS remain_VBP round_NN and_CC no_DT spreading_VBG occurs_VBZ ._. The_DT elongated_JJ
        dendritic-like_JJ processes_NNS in_IN C_NNP 3_CD treated_VBN HPB-ALL_NNP cells_NNS were_VBD
        F-_NNP actin_NN rich_JJ ._. This_DT phenotype_NN caused_VBN by_IN inactivation_NN of_IN Rho_NNP
        is_VBZ the_DT first_JJ to_TO be_VB described_VBN in_IN T_NN lymphocytes_NNS ,_, however_RB ,_, Rho_NNP
        regulation_NN of_IN the_DT actin_NN cytoskeleton_NN is_VBZ not_RB novel_NN among_IN
        cells_NNS of_IN the_DT hematopoietic_JJ lineage_NN ._. ADP-ribosylation_NNP of_IN Rho_NNP
        proteins_NNS in_IN chemoattractant_NN stimulated_VBN neutrophils_NNS [_NN 20_CD 21_CD
        ]_NN and_CC in_IN both_DT monocytic_JJ lines_NNS and_CC fresh_JJ blood_NN monocytes_NNS [_NN
        22_CD 38_CD ]_NN results_NNS in_IN actin_NN filament_NN polymerization_NN ._. Although_IN
        this_DT once_RB again_RB highlights_VBZ differences_NNS between_IN the_DT affects_VBZ
        of_IN C_NNP 3_CD in_IN fibroblasts_NNS and_CC leukocytes_NNS ,_, there_EX may_MD be_VB
        commonalties_NNS amongst_IN cells_NNS that_WDT do_VBP not_RB form_VB distinct_JJ actin_NN
        stress_NN fibers_NNS ,_, such_JJ as_IN leukocytes_NNS and_CC neuronal_NN cells_NNS ._.
        ADP-ribosylation_NNP of_IN Rho_NNP proteins_NNS by_IN C_NNP 3_CD exoenzyme_NN prevents_VBZ
        neurite_NN retraction_NN in_IN the_DT specialized_JJ growth_NN cone_NN of_IN
        developing_VBG neurons_NNS ,_, and_CC in_IN fact_NN promotes_VBZ neurite_NN outgrowth_NN
        in_IN the_DT same_JJ fashion_NN as_IN microinjection_NN of_IN purified_JJ dominant_JJ
        negative_JJ RhoA_NNP T_NN 19_CD N_NNP [_NN 39_CD ]_NN ._. In_IN these_DT instances_NNS ,_, neuronal_NN
        N_NNP 1_CD E-_NNP 115_CD cell_NN outgrowth_NN induced_VBN by_IN inactivation_NN of_IN RhoA_NNP was_VBD
        mimicked_JJ by_IN microinjection_NN of_IN Rac_NNP 1_CD -_: or_CC Cdc_NNP 42_CD -_: GST_NNP fusion_NN
        proteins_NNS ,_, and_CC could_MD be_VB abolished_VBN by_IN coinjection_NN of_IN dominant_JJ
        negative_JJ Cdc_NNP 42_CD T_NN 17_CD Nor_CC Rac_NNP 1_CD T_NN 17_CD N_NNP [_NN 39_CD ]_NN ._. From_IN these_DT
        results_NNS ,_, the_DT authors_NNS concluded_VBD that_DT inactivation_NN of_IN RhoA_NNP by_IN
        C_NNP 3_CD exoenzyme_NN treatment_NN resulted_VBD in_IN the_DT activation_NN of_IN Rac_NNP 1_CD
        and_CC Cdc_NNP 42_CD GTPases_NNP ,_, suggesting_VBG the_DT mutually_RB exclusive_JJ
        function_NN of_IN RhoA_NNP and_CC Rac_NNP 1_CD /_NN Cdc_NNP 42_CD ._. Cdc_NNP 42_CD has_VBZ been_VBN implicated_VBN
        in_IN the_DT formation_NN of_IN small_JJ ,_, actin-rich_JJ filopodia_NN [_NN 34_CD ]_NN ,_,
        which_WDT are_VBP similar_JJ to_TO those_DT seen_VBN on_IN spread_NN HPB-ALL_NNP cells_NNS
        (_( figure_NN 5_LS )_) around_IN the_DT periphery_NN of_IN the_DT cell_NN body_NN and_CC
        extended_VBN pseudopods_NNS ._. After_IN C_NNP 3_CD electroporation_NN ,_, HPB-ALL_NNP were_VBD
        allowed_VBN to_TO spread_VB on_IN VCAM-_NNP 1_CD for_IN 1_CD hour_NN ,_, and_CC
        TRITC-phalloidin_NNP staining_VBG demonstrated_VBD the_DT complete_JJ absence_NN
        of_IN fine_NN filopodial_NN structures_NNS ._. Given_VBN the_DT morphologic_JJ
        similarity_NN between_IN neurite_NN outgrowth_NN of_IN N_NNP 1_CD E-_NNP 115_CD cells_NNS and_CC
        the_DT aberrant_NN pseudopodial_NN extension_NN of_IN HPB-ALL_NNP when_WRB RhoA_NNP is_VBZ
        inhibited_VBD with_IN C_NNP 3_CD exoenzyme_NN ,_, it_PRP will_MD be_VB interesting_JJ to_TO
        determine_VB if_IN other_JJ GTPases_NNP such_JJ as_IN Rac_NNP or_CC Cdc_NNP 42_CD are_VBP
        activated_VBN to_TO promote_VB this_DT phenotype_NN after_IN C_NNP 3_CD treatment_NN of_IN
        HPB-ALL_NNP cells_NNS ._. The_DT thick_JJ actin_NN rich_JJ stellate_NN projections_NNS
        emanating_VBG from_IN the_DT cell_NN body_NN of_IN C_NNP 3_CD electroporated_JJ HPB-ALL_NNP
        may_MD be_VB the_DT result_NN of_IN condensation_NN of_IN filopodia_NN ,_, where_WRB Cdc_NNP 42_CD
        may_MD be_VB induced_VBN into_IN a_DT highly_RB active_JJ state_NN ._. Actin_NNP filament_NN
        elongation_NN would_MD continue_VB and_CC RhoA_NNP dependent_JJ retraction_NN of_IN
        filamentous_JJ actin_NN would_MD be_VB abrogated_JJ ._. This_DT could_MD occur_VB by_IN
        the_DT release_NN of_IN limited_JJ effector_NN molecules_NNS shared_VBN between_IN
        the_DT two_CD GTPases_NNP ,_, possibilities_NNS that_WDT are_VBP currently_RB under_IN
        investigation_NN ._.
        The_DT immunolocalization_NN of_IN RhoA_NNP in_IN normal_JJ and_CC C_NNP 3_CD treated_VBN
        cells_NNS did_VBD not_RB appear_VB drastically_RB different_JJ in_IN that_DT RhoA_NNP was_VBD
        apparent_JJ in_IN both_DT normal_JJ and_CC aberrant_NN pseudopodial_NN
        extensions_NNS ._. The_DT notable_JJ exception_NN was_VBD that_IN clusters_NNS of_IN RhoA_NNP
        appeared_VBD less_JJR diffuse_NN in_IN the_DT altered_VBN pseudopods_NNS of_IN C_NNP 3_CD
        treated_VBN cells_NNS (_( figure_NN 6_CD )_) ._. Although_IN ADP-ribosylation_NNP of_IN Rho_NNP
        does_VBZ not_RB significantly_RB alter_VB the_DT subcellular_NN distribution_NN
        of_IN RhoA_NNP ,_, Rho_NNP activity_NN is_VBZ inhibited_VBD ._. This_DT is_VBZ thought_VBN to_TO
        prevent_VB activation_NN of_IN downstream_JJ Rho_NNP targets_NNS required_VBN for_IN
        normal_JJ integrin_NN dependent_JJ morphological_JJ changes_NNS ._. A_DT number_NN
        of_IN potential_JJ downstream_JJ Rho_NNP effector_NN molecules_NNS have_VBP been_VBN
        identified_VBN recently_RB ._. These_DT include_VBP p_NN 150_CD RhoA-binding_NNP kinase_NN
        α_NN and_CC β_NN (_( p_NN 150_CD ROKα_NNP and_CC β_NN )_) [_NN 40_CD 41_CD ]_NN ,_, p_NN 160_CD Rho-associated_NNP
        coiled-coil_JJ containing_VBG protein_NN kinase_NN (_( Rho-p_NNP 160_CD ROCK_NNP )_) [_NN 42_CD ]_NN
        ,_, p_NN 164_CD Rho_NNP kinase_NN [_NN 43_CD ]_NN ,_, p_NN 120_CD protein_NN kinase_NN N_NNP (_( p_NN 120_CD PKN_NNP )_)
        [_NN 44_CD 45_CD ]_NN ,_, and_CC PKC-related_NNP kinase-_NN 2_CD (_( PRK-_NNP 2_LS )_) [_NN 46_CD ]_NN ._. These_DT
        kinases_NNS specifically_RB bind_NN to_TO the_DT GTP_NNP bound_VBN form_NN of_IN Rho_NNP ,_,
        except_IN for_IN PRK-_NNP 2_CD ,_, which_WDT can_MD bind_NN both_DT Rho_NNP and_CC Rac_NNP GTPases_NNP ._.
        Interestingly_RB ,_, inhibition_NN of_IN Rho-p_NNP 160_CD ROCK_NNP has_VBZ recently_RB been_VBN
        shown_VBN to_TO give_VB similar_JJ lymphocyte_NN morphology_NN as_IN inhibition_NN
        of_IN Rho_NNP with_IN C_NNP 3_CD [_NN 50_CD ]_NN ._. Another_DT interesting_JJ candidate_NN may_MD
        be_VB p_NN 120_CD PKN_NNP ,_, as_IN recent_JJ studies_NNS have_VBP established_VBN that_IN PKN_NNP
        phosphorylates_NNS cytoskeletal_NN intermediate_JJ filaments_NNS [_NN 47_CD ]_NN
        and_CC is_VBZ directly_RB linked_VBN to_TO the_DT cytoskeletal_NN network_NN through_IN
        associations_NNS with_IN α-actinin_JJ [_NN 48_CD ]_NN ._. Also_RB ,_, PKN_NNP may_MD be_VB
        involved_VBN in_IN relating_VBG cytoplasmic_JJ signals_NNS to_TO the_DT nucleus_NN ,_,
        for_IN in_IN response_NN to_TO stress_VB ,_, nuclear_JJ translocation_NN of_IN PKN_NNP
        occurs_VBZ [_NN 49_CD ]_NN ._. This_DT is_VBZ particularly_RB important_JJ in_IN light_NN of_IN
        previous_JJ work_NN demonstrating_VBG that_DT inactivation_NN of_IN Rho_NNP in_IN
        peripheral_JJ blood_NN T_NN lymphocytes_NNS inhibits_NNS costimulatory_NN
        signals_NNS up-regulating_JJ IL-_NNP 2_CD production_NN [_NN 25_CD ]_NN ._. Future_NNP
        experiments_NNS will_MD focus_VB on_IN determining_VBG the_DT relationship_NN of_IN
        Rho_NNP GTPases_NNP and_CC the_DT regulation_NN of_IN T_NN cell_NN morphology_NN [_NN 25_CD 51_CD
        52_CD ]_NN ._.
      
      
        Conclusions_NNP
        Inactivation_NNP of_IN Rho_NNP results_NNS in_IN an_DT active_JJ elongation_NN of_IN
        actin_NN rich_JJ ,_, finger-like_JJ dendritic_JJ processes_VBZ dependent_JJ on_IN β_NN 1_CD
        integrin_NN signaling_VBG ._. Thus_RB Rho_NNP activity_NN is_VBZ required_VBN for_IN T_NN
        lymphocyte_NN spreading_VBG morphologies_NNS ,_, and_CC is_VBZ required_VBN for_IN T_NN
        lymphocyte_NN motility_NN ._. In_IN static_JJ cell_NN adhesion_NN assays_NNS ,_,
        however_RB ,_, Rho_NNP activity_NN is_VBZ not_RB required_VBN to_TO maintain_VB
        constitutively_RB high_JJ levels_NNS of_IN adhesion_NN to_TO fibronectin_NN ._.
        Further_RB study_NN of_IN Rho_NNP and_CC it_PRP 's_VBZ related_VBN GTPases_NNP and_CC
        downstream_JJ effector_NN molecules_NNS ,_, will_MD be_VB important_JJ in_IN
        elucidating_VBG mechanisms_NNS regulating_VBG the_DT lymphocyte_NN
        cytoskeleton_NN and_CC thus_RB T_NN cell_NN function_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Reagents_NNP
          Poly-_NNP L-_NNP lysine_NN was_VBD purchased_VBN from_IN Sigma_NNP Chemical_NNP Co_NNP ._.
          (_( St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. Fn_NNP was_VBD affinity_NN purified_JJ from_IN 200_CD ml_NN of_IN
          human_JJ plasma_NN (_( Gulf_NNP Coast_NNP Regional_NNP Blood_NNP Center_NNP ,_, Houston_NNP ,_,
          TX_NNP )_) ._. Briefly_NNP ,_, gelatin-conjugated_JJ sepharose_NN bead_NN columns_NNS
          were_VBD pre-washed_JJ with_IN PBS_NNP containing_VBG 2_CD mM_NN EDTA_NNP and_CC 0_CD ._. 1_CD mM_NN
          PMSF_NNP ._. After_IN washing_VBG ,_, plasma_NN containing_VBG 2_CD mM_NN EDTA_NNP and_CC 0_CD ._. 1_CD
          mM_NN PMSF_NNP was_VBD passed_VBN over_IN the_DT column_NN twice_RB ,_, then_RB washed_VBN
          with_IN at_IN least_JJS 4_CD volumes_NNS of_IN PBS_NNP /_NN EDTA_NNP /_NN PMSF_NNP ._. Elution_NNP of_IN FN_NNP
          from_IN the_DT columns_NNS was_VBD performed_VBN with_IN 4_CD M_NNP urea_NN in_IN 0_CD ._. 15_CD M_NNP
          NaCl_NNP ,_, 2_CD mM_NN EDTA_NNP ,_, 0_CD ._. 1_CD mM_NN PMSF_NNP ,_, 20_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 8_CD ._. 0_CD ._.
          Collected_NNP fractions_NNS were_VBD dialyzed_JJ in_IN PBS_NNP ._. All_DT procedures_NNS
          were_VBD carried_VBN out_RB at_IN RT_NNP ._. Fn_NNP purity_NN was_VBD determined_VBN by_IN
          SDS-PAGE_NNP ._. VCAM-_NNP 1_CD was_VBD provided_VBN by_IN Dr_NNP ._. S_NNP ._. Fong_NNP (_( Genentech_NNP ,_,
          San_NNP Francisco_NNP ,_, CA_NNP )_) ._. C_NNP 3_CD exoenzyme_NN was_VBD purified_JJ as_IN
          previously_RB described_VBD [_NN 25_CD ]_NN ._. Anti-β_NNP 1_CD integrin_NN mAb_NN 33_CD B_NNP 6_CD
          and_CC anti_NN α_NN 4_CD β_NN 1_CD integrin_NN mAb_NN 19_CD H_NNP 8_CD were_VBD generated_VBN in_IN this_DT
          laboratory_NN and_CC have_VBP been_VBN previously_RB described_VBN [_NN 27_CD 28_CD ]_NN ._.
          Rabbit_NNP polyclonal_NN anti-_NN Cdc_NNP 42_CD ,_, -_: Rac_NNP 1_CD ,_, -_: Rac_NNP 2_CD ,_, -_: RhoA_NNP ,_, and_CC
          mouse_NN monoclonal_NN anti-_NN Ras_NNP ,_, were_VBD purchased_VBN from_IN Santa_NNP Cruz_NNP
          Biotechnology_NNP (_( Santa_NNP Cruz_NNP ,_, CA_NNP )_) ._.
        
        
          Cells_NNP
          The_DT T_NN cell_NN lines_NNS HPB-ALL_NNP and_CC CEM_NNP were_VBD maintained_VBN in_IN
          complete_JJ media_NNS (_( RPMI-_NNP 1640_CD supplemented_JJ with_IN 10_CD %_NN FBS_NNP ;_: 10_CD
          U_NNP /_NN ml_NN of_IN both_DT penicillin_NN and_CC streptomycin_NN ;_: and_CC 1_CD mM_NN
          L-G_NNP lutamine_NN ,_, all_DT from_IN Life_NNP Technologies_NNPS ,_, Grand_NNP Island_NNP ,_,
          NY_NNP )_) ._. Freshly_NNP isolated_VBD peripheral_JJ blood_NN T_NN cells_NNS were_VBD
          purified_JJ and_CC activated_VBN by_IN cross-linking_JJ CD_NNP 28_CD and_CC CD_NNP 3_CD as_RB
          previously_RB described_VBD [_NN 29_CD ]_NN ._.
        
        
          Time_NNP Lapse_NNP and_CC Fluorescence_NNP Microscopy_NNP
          HPB-ALL_NNP cells_NNS were_VBD plated_JJ on_IN VCAM-_NNP 1_CD in_IN the_DT temperature_NN
          controlled_VBD environment_NN of_IN an_DT inverted_JJ Nikon_NNP (_( Melville_NNP ,_,
          NY_NNP )_) Diaphot-_NNP TMD_NNP microscope_NN for_IN 1_CD hour_NN ._. During_IN this_DT time_NN ,_,
          images_NNS were_VBD obtained_VBN through_IN an_DT Optronics_NNP (_( Galeto_NNP ,_, CA_NNP )_)
          VI-_NNP 470_CD CCD_NNP camera_NN and_CC recorded_VBN by_IN time-lapse_JJ
          cinematography_NN on_IN a_DT Panasonic_NNP (_( Secaucus_NNP ,_, NJ_NNP )_) sVHS_NN AG-_NNP 6730_CD
          time-lapse_JJ videocassette_NN recorder_NN ._. Recordings_NNP were_VBD played_VBN
          back_RB and_CC digitized_JJ on_IN a_DT Macintosh_NNP IIVX_NNP computer_NN equipped_VBN
          with_IN a_DT Data_NNP Translation_NN (_( Marlboro_NNP ,_, MA_NNP )_) Frame_NNP Grabber_NNP card_NN
          using_VBG NIH_NNP IMAGE_NNP software_NN (_( available_JJ from_IN
          ftp_NN :_: /_NN /_NN codon_NN ._. nih_NN ._. gov_NN /_NN pub_NN /_NN nih-image_JJ /_NN nih-image_JJ 161_CD __NN fat_JJ ._. hqx_NN )_) ._.
          For_IN fluorescence_NN microscopy_NN ,_, glass_NN coverslips_NNS were_VBD
          coated_VBN with_IN Fn_NNP (_( 10_CD μg_NN /_NN ml_NN )_) ,_, VCAM-_NNP 1_CD (_( 5_CD μg_NN /_NN ml_NN )_) or_CC mAb_NN 19_CD H_NNP 8_CD
          (_( 0_CD ._. 5_LS μg_NN /_NN ml_NN )_) for_IN at_IN least_JJS 2_CD hours_NNS at_IN 37_CD °_NN C_NNP in_IN 50_CD mM_NN Tris_NNP
          (_( pH_NN 9_CD ._. 5_LS )_) ._. Coverslips_NNP were_VBD blocked_VBN with_IN BSA_NNP (_( 1_CD %_NN w_NN /_NN v_NN in_IN
          PBS_NNP )_) for_IN 30_CD min_NN at_IN room_NN temperature_NN then_RB washed_VBD with_IN PBS_NNP ._.
          HPB-ALL_NNP cells_NNS were_VBD then_RB plated_JJ onto_IN the_DT coverslips_NNS and_CC
          incubated_JJ for_IN 1_CD hour_NN at_IN 37_CD °_NN C_NNP in_IN complete_JJ media_NNS ._. The_DT cells_NNS
          were_VBD then_RB washed_VBN on_IN the_DT coverslips_NNS ,_, and_CC fixed_VBD with_IN 2_CD %_NN
          paraformaldehyde_NN for_IN at_IN least_JJS 30_CD min_NN at_IN 4_CD °_NN C_NNP ._. A_DT solution_NN
          of_IN 0_CD ._. 1_CD %_NN TritonX-_NNP 100_CD was_VBD then_RB used_VBN to_TO permeabilize_NN the_DT
          cells_NNS by_IN treatment_NN for_IN 10_CD min_NN at_IN 4_CD °_NN C_NNP ._. After_IN
          permeabilization_NN ,_, coverslips_NNS were_VBD again_RB blocked_VBN with_IN 1_CD %_NN
          BSA_NNP ._. After_IN washing_VBG in_IN PBS_NNP ,_, 80_CD μM_NN phalloidin-_NN TRITC_NNP or_CC 1_CD
          μg_NN /_NN ml_NN anti-_NN RhoA_NNP antibody_NN was_VBD incubated_JJ for_IN 30_CD min_NN at_IN 4_CD °_NN C_NNP ._.
          Cells_NNP were_VBD visualized_JJ on_IN a_DT Nikon_NNP DIAPHOT-TMD_NNP inverted_JJ
          microscope_NN and_CC images_NNS were_VBD digitized_JJ as_IN described_VBN
          above_IN ._.
        
        
          Western_NNP Blotting_NNP
          All_DT western_JJ blotting_VBG steps_NNS were_VBD carried_VBN out_RB at_IN 4_CD °_NN C_NNP for_IN
          at_IN least_JJS 2_CD hours_NNS ._. Cell_NNP lysates_NNS from_IN approximately_RB 2_CD ×_NN 10_CD
          6_CD cell_NN equivalents_NNS were_VBD subjected_VBN to_TO 12_CD ._. 5_LS %_NN SDS-PAGE_NNP ,_,
          transferred_VBN onto_IN PVDF_NNP membranes_NNS (_( Bio-rad_NNP ,_, Richmond_NNP ,_, CA_NNP )_) ,_,
          then_RB blocked_VBN with_IN 5_CD %_NN BSA_NNP and_CC 5_CD %_NN non-fat_JJ milk_NN ._. Membranes_NNP
          were_VBD extensively_RB washed_VBN ,_, then_RB incubated_JJ with_IN the_DT primary_JJ
          (_( 0_CD ._. 5_LS μg_NN /_NN ml_NN )_) polyclonal_NN anti-_NN RhoA_NNP ._. After_IN washing_VBG ,_,
          membranes_NNS were_VBD incubated_JJ with_IN Goat_NNP anti-rabbit_JJ polyclonal_NN
          antibody_NN conjugated_JJ to_TO HRP_NNP (_( Cappel_NNP ,_, Durham_NNP ,_, NC_NNP )_) ._.
          Chemiluminescence_NNP was_VBD performed_VBN as_IN described_VBN by_IN the_DT
          manufacturer_NN (_( Pierce_NNP ,_, Rockford_NNP ,_, IL_NNP )_) ._.
        
        
          Cell_NNP Adhesion_NNP Assays_NNP
          Adhesion_NNP assays_NNS were_VBD performed_VBN in_IN modified_VBN Tyrodes_NNP
          buffer_NN [_NN 30_CD ]_NN composed_VBN of_IN 12_CD mM_NN NaHCO_NNP 
          3_CD (_( pH_NN 7_CD ._. 4_LS )_) ,_, 150_CD mM_NN NaCl_NNP ,_, 2_CD ._. 5_CD mM_NN KCl_NNP ,_, 2_CD
          mM_NN MgCl_NNP 
          2_CD ,_, 1_CD mg_NN /_NN ml_NN BSA_NNP ,_, and_CC 1_CD mg_NN /_NN ml_NN glucose_NN ._.
          Plates_NNP were_VBD pre-coated_JJ with_IN Fn_NNP (_( 10_CD μg_NN /_NN ml_NN )_) for_IN at_IN least_JJS 2_CD
          hours_NNS at_IN RT_NNP in_IN 0_CD ._. 1_CD M_NNP NaHCO_NNP 
          3_CD ._. BSA_NNP (_( 2_CD %_NN w_NN /_NN v_NN )_) was_VBD then_RB added_VBN to_TO
          block_VB unbound_NN sites_NNS ._. Cells_NNP were_VBD resuspended_JJ in_IN modified_VBN
          Tyrodes_NNP buffer_NN ._. After_IN the_DT cells_NNS were_VBD added_VBN to_TO the_DT washed_VBN
          plates_NNS in_IN 100_CD μl_NN of_IN modified_VBN tyrodes_NNS (_( 1_CD ×_NN 10_CD 5_CD cells_NNS )_) ,_,
          plates_NNS were_VBD spun_VBN at_IN 300_CD rpm_NN for_IN 5_CD min_NN ,_, then_RB incubated_JJ for_IN
          45_CD min_NN at_IN 37_CD °_NN C_NNP and_CC 5_CD %_NN CO_NNP 
          2_CD ._. Two_CD images_NNS were_VBD digitized_JJ (_( see_VB
          above_IN )_) from_IN each_DT well_RB before_IN washing_VBG ,_, then_RB plates_NNS were_VBD
          carefully_RB washed_VBN 4_CD ×_NN with_IN pre-warmed_JJ (_( 37_CD °_NN C_NNP )_) modified_VBN
          Tyrodes_NNP buffer_NN ._. After_IN washing_VBG ,_, images_NNS from_IN the_DT same_JJ
          position_NN were_VBD digitized_JJ ._. Cell_NNP numbers_NNS were_VBD quantitated_JJ
          using_VBG NIH_NNP Image_NN software_NN ,_, and_CC adhesion_NN assays_NNS are_VBP graphed_JJ
          as_IN the_DT percentage_NN of_IN input_NN cells_NNS remaining_VBG after_IN
          washing_VBG ._.
        
        
          Electroporation_NNP of_IN C_NNP 3_CD into_IN HPB-ALL_NNP cells_NNS
          HPB-ALL_NNP cells_NNS were_VBD washed_VBN in_IN RPMI-_NNP 1640_CD and_CC resuspended_JJ
          between_IN 1_CD -_: 2_CD ×_NN 10_CD 6_CD cells_NNS per_IN 100_CD μl_NN RPMI-_NNP 1640_CD ._. Control_NN
          cells_NNS were_VBD electroporated_JJ with_IN the_DT indicated_VBN control_NN
          buffers_NNS ._. Cell_NNP samples_NNS were_VBD placed_VBN into_IN pre-chilled_JJ (_( 4_CD °_NN C_NNP )_)
          4_CD mm_NN or_CC 1_CD mm_NN electroporation_NN cuvettes_NNS (_( BTX_NNP Inc_NNP ._. ,_, San_NNP
          Diego_NNP ,_, CA_NNP )_) and_CC electroporated_JJ under_IN the_DT following_JJ
          conditions_NNS :_: 500_CD V_NNP /_NN capacitance_NN and_CC resistance_NN ,_, 1250_CD μF_NN
          capacitance_NN timing_NN ,_, 720_CD ohms_NNS resistance_NN ,_, and_CC 270_CD V_NNP for_IN 4_CD
          mm_NN gap_NN cuvettes_NNS or_CC 68_CD V_NNP for_IN 1_CD mm_NN gap_NN cuvettes_NNS (_( field_NN
          strength_NN of_IN ~_NN 700_CD Vcm_NNP -_: 1_LS )_) ._. Both_DT antibodies_NNS and_CC C_NNP 3_CD were_VBD
          electroporated_JJ at_IN a_DT final_JJ concentration_NN of_IN 25_CD μg_NN /_NN ml_NN ,_,
          incubated_JJ on_IN ice_NN for_IN 5_CD min_NN ,_, then_RB washed_VBN with_IN complete_JJ
          media_NNS at_IN room_NN temperature_NN and_CC used_VBN for_IN assays_NNS ._. Control_NN
          buffer_NN for_IN electroporation_NN of_IN C_NNP 3_CD consisted_VBD of_IN the_DT buffers_NNS
          used_VBN in_IN the_DT purification_NN of_IN C_NNP 3_CD ,_, including_VBG the_DT appropriate_JJ
          concentration_NN of_IN bovine_JJ α-thrombin_JJ [_NN 25_CD ]_NN ._. All_DT
          electroporation_NN of_IN proteins_NNS were_VBD carried_VBN out_IN on_IN an_DT
          Electro_NNP Cell_NNP Manipulator_NNP 600_CD (_( BTX_NNP Inc_NNP ._. )_) ._. This_DT procedure_NN
          had_VBD previously_RB been_VBN optimized_JJ for_IN intracellular_NN
          incorporation_NN of_IN macromolecules_NNS by_IN electroporation_NN of_IN
          goat_NN anti-mouse_JJ FITC_NNP conjugated_JJ antibodies_NNS ._.
          Electroporation_NNP efficiency_NN during_IN the_DT optimization_NN
          procedure_NN was_VBD monitored_VBN by_IN FACS_NNP analysis_NN and_CC fluorescence_NN
          imaging_NN (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          C_NNP 3_CD Ribosylation_NNP
          Purified_NNP C_NNP 3_CD or_CC BSA_NNP control_NN were_VBD electroporated_JJ at_IN a_DT
          concentration_NN of_IN 25_CD μg_NN /_NN ml_NN ._. After_IN electroporation_NN ,_, cells_NNS
          were_VBD transferred_VBN into_IN 1_CD ._. 5_CD ml_NN eppendorf_NN tubes_NNS and_CC
          incubated_JJ for_IN 1_CD hr_NN at_IN 37_CD °_NN C_NNP to_TO allow_VB ribosylation_NN ._. Cells_NNP
          were_VBD then_RB washed_VBN extensively_RB in_IN 1_CD %_NN BSA_NNP /_NN PBS_NNP to_TO remove_VB any_DT
          C_NNP 3_CD not_RB incorporated_VBN into_IN the_DT cells_NNS ._. Next_JJ ,_, the_DT cells_NNS were_VBD
          resuspended_JJ at_IN 3_CD ×_NN 10_CD 6_CD cells_NNS /_NN ml_NN in_IN ice_NN cold_JJ sonication_NN
          buffer_NN (_( 250_CD mM_NN sucrose_NN ;_: 10_CD mM_NN HEPES_NNP ,_, pH_NN 7_CD ._. 4_CD ;_: 1_CD mM_NN EDTA_NNP ;_: 5_CD
          mM_NN MgCl_NNP 
          2_CD ;_: 1_CD mM_NN DTT_NNP ;_: 0_CD ._. 1_CD mM_NN GTP_NNP ;_: 1_CD μg_NN /_NN ml_NN
          leupeptin_NN ,_, 1_CD μg_NN /_NN ml_NN pepstatin_NN A_DT ,_, and_CC 1_CD μg_NN /_NN ml_NN aprotinin_NN ;_: 1_CD
          mM_NN PMSF_NNP )_) and_CC sonicated_JJ for_IN 10_CD seconds_NNS ._. After_IN sonication_NN
          with_IN a_DT Sonic_NNP Dismembrator_NNP Model_NNP 300_CD with_IN microtip_NN
          (_( Fisher_NNP )_) ,_, 100_CD μl_NN of_IN the_DT mixture_NN was_VBD added_VBN to_TO 50_CD μl_NN of_IN 3_CD ×_NN
          reaction_NN buffer_NN containing_VBG 150_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 8_CD ._. 0_CD ;_: 30_CD mM_NN
          thymidine_NN ;_: 3_CD mM_NN DTT_NNP ;_: 5_CD mM_NN MgCl_NNP 
          2_CD ,_, 0_CD ._. 3_CD mM_NN GTP_NNP ._. To_TO this_DT mixture_NN ,_, 1_CD ._. 0_CD
          μg_NN purified_JJ C_NNP 3_CD and_CC 2_CD μCi_NN [_NN 32_CD P_NN ]_NN -_: NAD_NNP (_( NEN-Dupont_NNP ,_, Boston_NNP ,_,
          MA_NNP )_) were_VBD added_VBN ._. After_IN incubation_NN for_IN 1_CD hr_NN at_IN 37_CD °_NN C_NNP ,_, SDS_NNP
          was_VBD added_VBN to_TO 2_CD %_NN final_JJ w_NN /_NN v_NN and_CC this_DT mixture_NN was_VBD immersed_VBN
          in_IN a_DT boiling_VBG water_NN bath_NN for_IN 10_CD min_NN ._. Eight_CD volumes_NNS of_IN ice_NN
          cold_JJ ethanol_NN was_VBD then_RB added_VBN ,_, and_CC these_DT samples_NNS were_VBD kept_VBN
          at_IN -_: 20_CD °_NN C_NNP for_IN at_IN least_JJS 1_CD hr_NN ._. Precipitated_NNP proteins_NNS were_VBD
          pelleted_JJ ,_, and_CC dissolved_VBN in_IN SDS-PAGE_NNP sample_NN buffer_NN by_IN
          boiling_VBG for_IN 10_CD min_NN ._. Samples_NNP were_VBD then_RB subjected_VBN to_TO 12_CD ._. 5_LS %_NN
          SDS-PAGE_NNP and_CC analyzed_VBN by_IN autoradiography_NN ._.
        
      
      
        Authors_NNP '_'' Contributions_NNP
        DGW_NNP drafted_VBD the_DT manuscript_NN ,_, performed_VBD ADP-ribosylation_NNP
        experiments_NNS ,_, adhesion_NN and_CC spreading_VBG assays_NNS ,_, and_CC
        immunofluorescence_NN ._. DKW_NNP and_CC TU_NNP expressed_VBD and_CC purified_JJ C_NNP 3_CD
        exoenzyme_NN ._. TKT_NNP performed_VBD initial_JJ spreading_VBG experiments_NNS and_CC
        video_NN time_NN lapse_NN microscopy_NN ._. YM_NNP performed_VBD experiments_NNS on_IN
        activated_VBN human_JJ T_NN cells_NNS ._. EGC_NNP helped_VBD generate_VB the_DT methods_NNS to_TO
        electroporate_NN suspension_NN cells_NNS with_IN C_NNP 3_CD exotoxin_NN ._. BFA_NNP
        quantitated_JJ the_DT time-resolved_JJ morphological_JJ alterations_NNS ._.
        BWM_NNP aided_VBD in_IN the_DT conception_NN ,_, design_NN ,_, and_CC implementation_NN of_IN
        the_DT experiments_NNS ,_, and_CC edited_JJ the_DT manuscript_NN ._.
      
    
  
